Best Glow Stack Suppliers in 2026: 35 Vendors Priced

Twenty-three sellers had a 70 mg Glow vial in stock when we priced the market last week. The cheapest was $60.91. The most expensive was $189.99. Same three peptides, same ratio on the label, and a 3.1x gap between the two ends.

That gap is why we built this list. Glow is a premixed blend of GHK-Cu, BPC-157, and TB-500, and 35 of the vendors we track sell some version of it. Below are the five we would shop, why each one earned its spot, and what to check before you order.

What is actually in the vial

The market has settled on one recipe: 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-500, for 70 mg total. Several sellers spell it out right in the product name ("cu50tb10bpc10"). Copper peptide makes up most of the weight.

Older protocols, including our own Glow Stack guide, paired GHK-Cu and BPC-157 with ipamorelin. The premixed product sold today is the three-way GHK-Cu, BPC-157, TB-500 blend, so that is what we priced.

Formats vary more than you would expect:

Stick to the 70 mg vial if you want to compare prices honestly. It is the one format where a dollar figure means the same thing at every store.

Is the blend a good deal?

Usually, yes. At the median per-mg price in our data, buying the three peptides separately runs about $160 for the same 70 mg ($35 of GHK-Cu, $55 of BPC-157, $70 of TB-500). The median 70 mg Glow vial costs $114.

Bargain hunters who already buy single peptides from the cheapest stores can match the blend price on their own. For everyone else, one vial, one reconstitution, and one COA to read is simpler and cheaper.

The five sellers we would shop

We score every vendor on third-party lab testing, price, reputation, US availability, catalog depth, and payment options. The scores below match what you will see on each vendor scorecard.

Orbitrex rates 9.0 out of 10, the highest of any seller stocking the standard 70 mg Glow. Its lab tier is Finnrick, the strongest third-party testing source in our rubric. It ships from Flower Mound, Texas, and the vial is $99.99, below the market median. Top score and a below-median price is a rare pairing, so this is where we would start.

Peptide Crafters charges $85 for the 70 mg vial, the lowest price we found from any Finnrick-tier seller. Its overall rating is 8.3 out of 10, helped by a strong price sub-score and a deep catalog. If you want top-tier testing and care about every dollar, this is the one.

Penguin rates 8.0 out of 10 and backs its catalog with Janoshik results, one of the most widely cited independent labs in the hobby. At $124 it sits a little above the median. You pay a small premium for a seller whose lab-testing score matches the top two.

Based in the Greater Toronto Area, Panda ships to the US and lists the 70 mg vial at $89.99. It rates 7.8 out of 10, with Janoshik as its lab source and one of the best price sub-scores on this list. A good fit for Canadian buyers and for anyone who likes Panda's pricing across the rest of its catalog.

Umbrella Labs in Tucson has the lowest 70 mg price of any US-based shop we track at $79.97, plus a 90 mg vial at $109.99. It rates 7.1 out of 10 and uses MZ Biolabs for testing. Pick it when price leads and you are happy reading the COA yourself.

One more name worth knowing: Peptidology, the highest-rated vendor on our entire board at 9.3, sells Glow in a smaller 10 mg vial for $109. It suits buyers who want a small run from the top-scored shop. The full ranked list lives on our Glow Stack page.

What a great Glow seller shows you

A blend is harder to verify than a single peptide. A good COA for Glow reports each component separately, so you can see GHK-Cu, BPC-157, and TB-500 each landing near 50, 10, and 10 mg. A single "purity 99%" figure for the whole vial tells you much less.

Three things we look for:

Our guide on how to read a peptide COA walks through the layout line by line. For single-peptide sellers, see our rankings for GHK-Cu and TB-500, or browse every scored seller on the vendors page.

Where the rules stand

Glow is sold for research use, and none of its three peptides is FDA-approved. The picture is moving. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 and TB-500 to the 503A bulks list, and GHK-Cu is due for its own review before February 2027. The FDA still has to act on those recommendations. Our reclassification explainer has the details. As always, talk to your doctor before starting anything new.

Sources